Haloprogin
Back to searchMolecule Structure
Scientific Name
Haloprogin
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00793
http://www.drugbank.ca/drugs/DB00793
Brand Name(s)
Halotex, Mycanden
Company Owner(s)
Westwood Squibb Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cell membrane | SUBCELLULAR | INHIBITOR | CHEMBL2364033 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3649 |
PharmGKB | PA164768737 |
Human Metabolome Database | HMDB0014931 |
DrugBank | DB00793 |
PubChem: Thomson Pharma | 14953597 |
PubChem | 3561 |
LINCS | LSM-5310 |
Nikkaji | J3.326J |
BindingDB | 50194601 |
EPA CompTox Dashboard | DTXSID9046865 |
DrugCentral | 1355 |
Brenda | 24564 |
ChemicalBook | CB4501419 |
rxnorm | HALOPROGIN |
ChEBI | 5614 |
ZINC | ZINC000001530649 |